Collaborations & Alliances

Pelago Bioscience and AstraZeneca Form Pact

Enter into research collaboration and license agreement on the CETSA method

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pelago Bioscience AB and AstraZeneca have entered into a 2-year strategic research collaboration and license agreement. The companies will collaborate on specified joint projects and AstraZeneca will also be granted a license to use and apply the Cellular Thermal Shift Assay (CETSA) for determination and quantification of drug–target interactions in other AstraZeneca discovery projects. During the collaboration Pelago and AstraZeneca will together develop assay formats and applications of the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters